A Full-Thickness Skin Graft In Women With Recurrent Basal Cell Carcinoma In The Right Infraorbital Region: One Case Report

Authors

  • Zilpa Widyastuti Department of Dermatovenereology, Faculty of Medicine Sebelas Maret University, Dr. Moewardi General Hospital Surakarta, Indonesia.
  • Moerbono Mochtar Department of Dermatovenereology, Faculty of Medicine Sebelas Maret University, Dr. Moewardi General Hospital Surakarta, Indonesia.
  • Prasetyadi Mawardi Department of Dermatovenereology, Faculty of Medicine Sebelas Maret University, Dr. Moewardi General Hospital Surakarta, Indonesia.

Keywords:

Basal cell carcinoma, Fullthickness skin graft, Infraorbita

Abstract

Abstract Introduction: Basal cell carcinoma (BCC) is a malignancy of the skin that mainly occurs in skin that is frequently exposed to sunlight. The first choice of treatment for BCC is excision. Excision is usually followed by reconstruction, as in this case report using a full-thickness skin graft reconstruction technique. Case: A 32-year-old woman came with a complaint of a lump appeared on the bottom of her right eye since a few weeks ago. The patient had previously been diagnosed with BCC in the same location about 1 year ago. The conclusion from histopathological examination of the lesion is BCC. The chosen management are excision of the tumor and reconstruction using the full-thickness skin graft technique. Discussion: Basal cell carcinoma generally occurs on the face and affects elderly population, but recently it is often found in groups of young adults. The main environmental risk factor that plays a role in the development of BCC is ultraviolet exposure. Management of BCC is usually done with surgery such as excisional biopsy followed by reconstruction such as skin graft. Conclusion: Basal cell carcinoma is the most common skin cancer. Excisional biopsy is helpful in differentiating skin tumors, inflammatory processes, and other dermal lesions. Skin grafts are an option when primary closure or flap repair are deemed unsuitable. Keywords: Basal cell carcinoma, fullthickness skin graft, infraorbita.

References

Dai J, Lin K, Huang Y, Lu Y, Chen WQ, Zhang XR, dkk. Identification of critically carcinogenesis-related genes in basal cell carcinoma. Onco targets ther. 2018; 11: 6957–67.

Kappelin, J., Green, A.C., Ingvar, Å., Ahnlide, I. and Nielsen, K. Incidence and trends of basal cell carcinoma in Sweden: a population-based registry study. Br J Dermatol, 2022; 186: 963-969.

Cameron MC, Lee E, Hibler BP, Barker CA, Mori S, Cordova M, dkk. Basal cell carcinoma: Contemporary approaches to diagnosis, treatment, and prevention. J Am Acad Dermatol. 2019; 80(2): 303–17.

Asgari MM, Moffet HH, Ray GT, Quesenberry CP. Trends in basal cell carcinoma incidence and identification of high-risk subgroups, 1998-2012. JAMA Dermatol. 2015;151(9):976–981.

Tang JY, Epstein, Jr. EH, Oro AE. Basal cell carcinoma and basal cell nevus syndrome. Dalam: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, Orringer JS. Fitzpatrick's Dermatology, 9th ed. California: McGraw Hill; 2019: 197-230.

Al-Qarqaz F, Marji M, Bodoor K, Almomani R, Al Gargaz W, Alshiyab D, dkk. Clinical and demographic features of basal cell carcinoma in north jordan. J Skin Cancer. 2018; 18(1): 1–5.

Mackiewicz-Wysocka M, Bowszyc-Dmochowska M, Strzelecka-Węklar D, Dańczak- Pazdrowska A, Adamski Z. Reviews basal cell carcinoma – diagnosis. Współczesna Onkol. 2013; 4: 337–42.

Berking C, Hauschild A, Kölbl O, Mast G, Gutzmer R. Basal cell carcinoma-treatments for the commonest skin cancer. Dtsch Arztebl Int. 2014;111(22):389-395.

Gangan R. Basal cell carcinoma: epidemiology. J Skin Sex Transm Dis. 2022;14(1): 782- 791.

De Giorgi V, Savarese I, Gori A, Scarfi F, Topa A, Trane L, dkk. Advanced basal cell carcinoma: when a good drug is not enough. J Dermatolog Treat. 2020; 31(6): 552–3.

Peris K, Fargnoli MC, Garbe C, Kaufmann R, Bastholt L, Seguin NB, dkk. Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines. Eur J Cancer. 2019; 118: 10–34.

Tanese K. Diagnosis and management of basal cell carcinoma. Curr Treat Options Oncol. 2019; 20(2): 13.

Kaliki S, Bothra N, Bejjanki KM, et al. Malignant eyelid tumors in india: A study of 536 asian indian patients. Ocul Oncol Pathol. 2019;5(3):210-219..

Peterson SC, Eberl M, Vagnozzi AN, Belkadi A, Veniaminova NA, Verhaegen ME, dkk. Basal cell carcinoma preferentially arises from stem cells within hair follicle and mechanosensory niches. Cell Stem Cell. 2015; 16(4): 400–12.

Atwood SX, Sarin KY, Whitson RJ, Li JR, Kim G, Rezaee M, dkk. Smoothened variants explain the majority of drug resistance in basal cell carcinoma. Cancer Cell. 2015; 27(3): 342–53.

Marzuka AG, Book SE. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J Biol Med. 2015; 88(2): 167– 79.

Skoda AM, Simovic D, Karin V, Kardum V, Vranic S, Serman L. The role of the Hedgehog signaling pathway in cancer: A comprehensive review. Bosn J Basic Med Sci. 2018;18(1):8- 20.

Marzuka AG, Book SE. Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management. Yale J Biol Med. 2015; 88(2): 167– 79.

Kim DP, Kus KJB, Ruiz E. Basal cell carcinoma review. Hematol Oncol Clin North Am. 2019; 33(1): 13–24.

Vílchez-Márquez F, Borregón-Nofuentes P, Barchino-Ortiz L, et al. Diagnosis and treatment of basal cell carcinoma in specialized dermatology units: A clinical practice guideline. Actas Dermosifiliogr. 2020;111(4):291-99.

Behera B, Kumari R, Thappa DM, Gochhait D, Srinivas BH, Ayyanar P. Dermoscopic features of basal cell carcinoma in skin of color: A retrospective cross-sectional study from Puducherry, South India. Indian J Dermatol Venereol Leprol. 2021; 23; 1.

Reiter O, Mimouni I, Gdalevich M, Marghoob AA, Levi A, Hodak E, dkk. The diagnostic accuracy of dermoscopy for basal cell carcinoma: A systematic review and meta-analysis. J Am Acad Dermatol. 2019; 80(5): 1380–8.

Kueder-Pajares T, Descalzo MA, García-Doval I, Ríos-Buceta L, Moreno-Ramírez D. Evaluation of structure indicators for assessing skin cancer quality of care in dermatology departments. Actas Dermosifiliogr. 2018;109(9):807-12.

Diago A, Requena L, Traves V, Requena C. Solid microcystic adnexal carcinoma on the thigh: An unusual location. Am J Dermatopathol. 2020;42(2):122-124.

Gerall CD, Sippel MR, Yracheta JL, Hogan FS. Microcystic adnexal carcinoma: A rare, commonly misdiagnosed malignancy. Mil Med. 2019;184(11-12):948-50.

Trufant JW, Marzolf S, Leach BC, Cook J. The utility of full-thickness skin grafts (FTSGs) for auricular reconstruction. J Am Acad Dermatol. 2016; 75(1): 169–76.

Zlatarova ZI, Nenkova BN, Softova EB. Eyelid reconstruction with full thickness skin grafts after carcinoma excision. Folia Med. 2016;58(1):42-47.

Kanapathy M, Smith OJ, Hachach-Haram N, Bystrzonowski N, Mosahebi A, Richards T. Systematic review and meta-analysis of the efficacy of epidermal grafting for wound healing. Int Wound J. 2017; 14(6): 921–8.

Choi CJ, Bauza A, Yoon MK, Sobel RK, & Freitag SK. Full-thickness skin graft as an independent or adjunctive technique for repair of cicatricial lower eyelid ectropion secondary to actinic skin changes. Ophthalmic Plastic and Reconstructive Surgery. 2015; 31(6), 474–77.

Downloads

Published

2023-08-07

How to Cite

1.
Widyastuti Z, Mochtar M, Mawardi P. A Full-Thickness Skin Graft In Women With Recurrent Basal Cell Carcinoma In The Right Infraorbital Region: One Case Report. J Pak Assoc Dermatol [Internet]. 2023Aug.7 [cited 2024Jul.13];33(3):1112-8. Available from: http://www.jpad.com.pk/index.php/jpad/article/view/2259

Issue

Section

Case Reports